This year, about 200,000 people will be diagnosed with non-small-cell lung cancer, the second leading cause of death after cardiovascular disease. Researchers are working to improve the odds for these patients in two recently published studies that combine novel multiplex cellular imaging methods with artificial intelligence to learn why and how patients respond differently to disease and treatments.
Click here for original story, Zooming in on the signals of cancer
Source: ScienceDaily